Everyday Health on MSN6h
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
New Scientist9h
GLP-1 drugs are only the start – the powerful drugs to expect next
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...
Healio10h
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) ...
Soleno jumps as analysts say US nod for rare disease drug transforms treatment options
Shares of Soleno Therapeutics jumped 40% in morning trading on Thursday, after the company's drug for a rare metabolic condition became the first such treatment to receive U.S. regulatory nod.
Zacks Investment Research on MSN15h
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug
Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR ...
FBC News22h
New Met facility to open in Nadi
Fiji is poised to become the Pacific’s leading center for disaster risk reduction and meteorological services. This as a new ...